CLPBF vs CSBTF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPBF is a Hold and CSBTF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CLPBF’s FA Score shows that 2 FA rating(s) are green whileCSBTF’s FA Score has 1 green FA rating(s).
- CLPBF’s FA Score: 2 green, 3 red.
- CSBTF’s FA Score: 1 green, 4 red.
Price Growth
CLPBF (@Medical Specialties) experienced а -4.15% price change this week, while CSBTF (@Medical Specialties) price change was -7.69% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.
Industries' Descriptions
@Medical Specialties (-4.23% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| CLPBF | CSBTF | CLPBF / CSBTF | |
| Capitalization | 26.5B | 99.1M | 26,741% |
| EBITDA | 7.65B | -8.84M | -86,493% |
| Gain YTD | 7.718 | 679.120 | 1% |
| P/E Ratio | 36.76 | N/A | - |
| Revenue | 24.1B | 18M | 133,889% |
| Total Cash | 881M | 24.1M | 3,656% |
| Total Debt | 22.2B | 1.91M | 1,160,481% |
CLPBF | CSBTF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 8 Undervalued | 59 Fair valued | |
PROFIT vs RISK RATING 1..100 | 90 | 2 | |
SMR RATING 1..100 | 22 | 91 | |
PRICE GROWTH RATING 1..100 | 56 | 34 | |
P/E GROWTH RATING 1..100 | 70 | 100 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CLPBF's Valuation (8) in the null industry is somewhat better than the same rating for CSBTF (59). This means that CLPBF’s stock grew somewhat faster than CSBTF’s over the last 12 months.
CSBTF's Profit vs Risk Rating (2) in the null industry is significantly better than the same rating for CLPBF (90). This means that CSBTF’s stock grew significantly faster than CLPBF’s over the last 12 months.
CLPBF's SMR Rating (22) in the null industry is significantly better than the same rating for CSBTF (91). This means that CLPBF’s stock grew significantly faster than CSBTF’s over the last 12 months.
CSBTF's Price Growth Rating (34) in the null industry is in the same range as CLPBF (56). This means that CSBTF’s stock grew similarly to CLPBF’s over the last 12 months.
CLPBF's P/E Growth Rating (70) in the null industry is in the same range as CSBTF (100). This means that CLPBF’s stock grew similarly to CSBTF’s over the last 12 months.
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| THYF | 52.33 | -0.13 | -0.26% |
| T. Rowe Price U.S. High Yield ETF | |||
| WBIG | 24.78 | -0.09 | -0.38% |
| WBI BullBear Yield 3000 ETF | |||
| HGER | 22.14 | -0.10 | -0.45% |
| Harbor Commodity All-Weather StrategyETF | |||
| GSUS | 80.66 | -1.15 | -1.41% |
| Goldman Sachs MarketBeta US Equity ETF | |||
| WEIX | 26.71 | -0.48 | -1.77% |
| Dynamic Short Short-Term Volatil Fut ETF | |||
CLPBF and
Correlation & Price change
A.I.dvisor indicates that over the last year, CLPBF has been loosely correlated with CLPBY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPBF jumps, then CLPBY could also see price increases.
| Ticker / NAME | Correlation To CLPBF | 1D Price Change % | ||
|---|---|---|---|---|
| CLPBF | 100% | N/A | ||
| CLPBY - CLPBF | 38% Loosely correlated | -0.78% | ||
| AHICF - CLPBF | 26% Poorly correlated | N/A | ||
| WILLF - CLPBF | 22% Poorly correlated | N/A | ||
| QDEL - CLPBF | 20% Poorly correlated | -7.14% | ||
| ESLOY - CLPBF | 20% Poorly correlated | +0.42% | ||
More | ||||
CSBTF and
Correlation & Price change
A.I.dvisor tells us that CSBTF and APYX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSBTF and APYX's prices will move in lockstep.
| Ticker / NAME | Correlation To CSBTF | 1D Price Change % | ||
|---|---|---|---|---|
| CSBTF | 100% | -14.85% | ||
| APYX - CSBTF | 22% Poorly correlated | -2.33% | ||
| DIZTF - CSBTF | 4% Poorly correlated | N/A | ||
| CHEOY - CSBTF | 2% Poorly correlated | -0.13% | ||
| CLPBF - CSBTF | 2% Poorly correlated | N/A | ||
| CNVVF - CSBTF | 1% Poorly correlated | N/A | ||
More | ||||